Sepsis remains a major clinical challenge due to dysregulated inflammation. Here, the authors develop a chemogenetic RNA-editing system using bioengineered lentiviruses to target and downregulate NLRP3 mRNA in inflammatory macrophages, offering a controllable and effective strategy for sepsis treatment.
- Wensong Xi
- Youcui Xu
- Yuan Ping
